Canada markets open in 6 hours 15 minutes
  • S&P/TSX

    20,231.32
    +73.67 (+0.37%)
     
  • S&P 500

    4,246.59
    -8.56 (-0.20%)
     
  • DOW

    34,299.33
    -94.42 (-0.27%)
     
  • CAD/USD

    0.8213
    +0.0004 (+0.05%)
     
  • CRUDE OIL

    72.53
    +0.41 (+0.57%)
     
  • BTC-CAD

    49,146.84
    -71.81 (-0.15%)
     
  • CMC Crypto 200

    1,002.60
    -8.01 (-0.79%)
     
  • GOLD FUTURES

    1,861.30
    +4.90 (+0.26%)
     
  • RUSSELL 2000

    2,320.07
    -6.07 (-0.26%)
     
  • 10-Yr Bond

    1.4990
    0.0000 (0.00%)
     
  • NASDAQ futures

    14,051.25
    +21.00 (+0.15%)
     
  • VOLATILITY

    17.02
    +0.63 (+3.84%)
     
  • FTSE

    7,174.19
    +1.71 (+0.02%)
     
  • NIKKEI 225

    29,291.01
    -150.29 (-0.51%)
     
  • CAD/EUR

    0.6772
    +0.0007 (+0.10%)
     

Minerva Neurosciences: Q1 Earnings Snapshot

·1 min read

WALTHAM, Mass. (AP) _ Minerva Neurosciences Inc. (NERV) on Wednesday reported a loss of $8.8 million in its first quarter.

On a per-share basis, the Waltham, Massachusetts-based company said it had a loss of 21 cents.

The results missed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for earnings of 20 cents per share.

The company's shares closed at $2.23. A year ago, they were trading at $12.55.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on NERV at https://www.zacks.com/ap/NERV

The Associated Press